Detail of the clinical trial

Title of the trial An open-labeled, randomized, two-dose, paralel group trial of ofatumumab, a fully human monoclonal anti-CD20 antibody, in combination with fludarabine and cyclophosphamide, in patiens with previously untreated B-cellchronic Lymphocytic leukemia
EudraCT number 2007-000243-10
Protocol number Hx-CD20-407
Sponsor Genmab A/S, Dansko
Indications Hemato-oncology
Diagnosis CLL
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2007
Date of approval by Institute (SÚKL) 24.01.2008
Date of approval by EC 17.01.2008
Date of initiation CT in ČR 27.03.2008 0:00:00
Date of ending CT in ČR 14.8.2013
Sites Interní hematoonkologická klinika, FN Brno-Bohunice, Jihlavská 20, Brno
II. interní klinka, oddělení klinické hematologie, FN Hradec Králové, Sokolská 581, Hradec Králové
Interní hematoonkologická klinika, VFN v Praze, U Nemocnice 2, Praha
Oddělení klinické hematologie, FN Královské Vinohrady, Šrobárova 50, Praha

‹‹ Back to list